ArticleFrontiers in allergy2026

Microcrystalline tyrosine as a novel depot-forming agent in venom immunotherapy: a pre-clinical evaluation in bee-venom allergic mice.

Marta Paolucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.